Back

mr. L.M. (Kenneth) Asselt

mr. L.M. (Kenneth) Asselt

Associate Professor

Show full profile

Research Output (164)

Early Assessment of Axillary Response with F-18-FDG PET/CT during Neoadjuvant Chemotherapy in Stage II-III Breast Cancer: Implications for Surgical Management of the Axilla

Koolen B.B., Valdes Olmos R.A., Wesseling J., Vogel W.V., Vincent A.D., Gilhuijs K.G.A., Rodenhuis S, Rutgers E.J., Vrancken Peeters M.J. Jul 2013, In: Annals of Surgical Oncology. 20 , p. 2227-2235

Semi-automated primary tumor volume measurements by dynamic contrast-enhanced MRI in patients with head and neck cancer

Lodder W.L., Gilhuijs K.G.A., Lange C.A., Pameijer F.A., Balm A.J., van den Brekel M.W.M. 2013, In: Head and Neck. 35 , p. 521-526 6 p.

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer

Koolen B.B., Pengel K.E., Wesseling J., Vogel W.V., Vrancken Peeters M.J., Vincent A.D., Gilhuijs K.G.A., Rodenhuis S, Rutgers E.J., Valdes Olmos R.A. 2013, In: The Breast. 22 , p. 691-697 7 p.

Fully automated deformable registration of breast DCE-MRI and PET/CT

Dmitriev I.D., Loo C.E., Vogel W.V., Pengel K.E., Gilhuijs K.G.A. 2013, In: Physics in Medicine and Biology. 58 , p. 1221-1233 13 p.

Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer

Rigter L.S., Loo C.E., Linn S.C., Sonke G.S., van Werkhoven E., Lips E.H., Warnars H.A., Doll P.K., Bruining A., Mandjes I.A.M., Vrancken Peeters M.J., Wesseling J., Gilhuijs K.G.A., Rodenhuis S 2013, In: British Journal of Cancer. 109 , p. 2965-2972 8 p.

Dynamic contrast-enhanced and ultra-high-resolution breast MRI at 7.0 Tesla

Stehouwer B.L., Klomp D.W.J., van den Bosch M.A.A.J., Korteweg M.A., Gilhuijs K.G.A., Witkamp A.J., van Diest P.J., Houwert K.A.F., van der Kemp W.J.M., Luijten P.R., Mali W.P.T.M., Veldhuis W.B. 2013, In: European Radiology. 23 , p. 2961-2968 8 p.

MR-guided High-Intensity Focused Ultrasound ablation of breast cancer with a dedicated breast platform

Merckel L.G., Bartels L.W., Köhler M.O., van den Bongard H.J.G.D., Deckers R.H.R., Mali W.P.T.M., Binkert C.A., Moonen C.T.W., Gilhuijs K.G.A., van den Bosch M.A.A.J. 2013, In: Cardiovascular and Interventional Radiology. 36 , p. 292-301 10 p.

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy

Koolen B.B., Vrancken Peeters M.J., Wesseling J., Lips E.H., Vogel W.V., Aukema T.S., van Werkhoven E., Gilhuijs K.G.A., Rodenhuis S., Rutgers E.J., Valdes Olmos R.A. Dec 2012, In: European Journal of Nuclear Medicine and Molecular Imaging. 39 , p. 1830-1838

MRI of the breast in patients with DCIS to exclude the presence of invasive disease

Deurloo E.E., Sriram J.D., Teertstra H.J., Loo C.E., Wesseling J., Rutgers E.J., Gilhuijs K.G.A. Jul 2012, In: European Radiology. 22 , p. 1504-1511

Extending the Webb-Nahum Tumour Control Probability Model for Breast Conserving Therapy

Chen W., Gilhuijs K., Stroom J., Sonke J-J Jun 2012, In: Medical Physics. 39 , p. 3994-3995

Thank you for your review!

Has this information helped you?
Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not